Will Dynavax’ HBV Vaccine Resubmission Make The Safety Grade?
This article was originally published in The Pink Sheet Daily
Executive Summary
Company says it now has enough safety data to support a new FDA filing in the first quarter of 2016, and that it expects a superiority claim for diabetics.